Skip to main content

Table 2 Results of the network meta-analysis for the clinical effectiveness rate (upper-right quadrant) and the incidence of ADRs (lower-left quadrant)

From: Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis

BQ

1.54 (0.42,6.03)

0.28 (0.033,2.31)

0.58 (0.25,1.35)

0.35 (0.19,0.66)

0.27 (0.10,0.67)

0.57 (0.10,3.13)

0.55 (0.15,2.04)

1.17 (0.50,2.79)

0.85 (0.24,2.98)

0.82 (0.45,1.48)

0.22 (0.13,0.39)

–

FufangFSN

0.19 (0.032,0.92)

0.38 (0.095,1.43)

0.23 (0.065,0.75)

0.17 (0.038,0.74)

0.37 (0.049,2.74)

0.36 (0.066,1.90)

0.76 (0.19,2.94)

0.55 (0.10,2.81)

0.53 (0.15,1.78)

0.15 (0.042,0.47)

–

–

JGL

2.05 (0.25,18.11)

1.25 (0.16,10.08)

0.95 (0.10,8.95)

2.02 (0.15,28.02)

1.94 (0.19,21.21)

4.14 (0.49,37.31)

2.99 (0.29,31.93)

2.88 (0.37,23.56)

0.79 (0.10,6.38)

2.63 (1.10,6.31)

–

–

KX

0.61 (0.30,1.20)

0.46 (0.16,1.30)

0.98 (0.17,5.47)

0.94 (0.25,3.55)

2.02 (0.82,4.93)

1.45 (0.39,5.31)

1.40 (0.69,2.80)

0.39 (0.20,0.77)

3.42 (1.80,6.69)

–

–

1.30 (0.67,2.55)

GTW

0.76 (0.31,1.85)

1.61 (0.32,8.34)

1.55 (0.47,5.33)

3.32 (1.65,6.85)

2.39 (0.74,7.78)

2.30 (1.51,3.54)

0.64 (0.46,0.87)

2.71 (1.04,7.17)

–

–

1.03 (0.39,2.76)

0.79 (0.36,1.74)

LGT

2.13 (0.35,13.24)

2.04 (0.49,8.86)

4.39 (1.52,12.82)

3.16 (0.77,13.02)

3.05 (1.25,7.51)

0.84 (0.36,1.95)

1.09 (0.15,6.81)

–

–

0.41 (0.055,2.58)

0.32 (0.046,1.80)

0.39 (0.051,2.63)

QWTB

0.96 (0.13,6.99)

2.06 (0.36,11.69)

1.48 (0.21,10.59)

1.43 (0.28,7.31)

0.39 (0.078,1.93)

0.35 (0.070,1.40)

–

–

0.13 (0.027,0.53)

0.10 (0.023,0.36)

0.13 (0.024,0.55)

0.32 (0.033,3.20)

WB

2.14 (0.56,8.09)

1.55 (0.30,7.76)

1.49 (0.43,4.94)

0.41 (0.12,1.29)

2.22 (0.88,5.59)

–

–

0.84 (0.33,2.12)

0.65 (0.31,1.33)

0.82 (0.30,2.26)

2.04 (0.32,15.63)

6.38 (1.55,32.01)

YSJB

0.72 (0.19,2.67)

0.70 (0.33,1.43)

0.19 (0.098,0.36)

0.28 (0.027,1.95)

–

–

0.11 (0.010,0.75)

0.083 (0.0085,0.52)

0.10 (0.0097,0.76)

0.26 (0.015,3.68)

0.82 (0.063,8.61)

0.13 (0.012,0.91)

YXB

0.96 (0.31,3.04)

0.27 (0.084,0.83)

2.30 (1.21,4.55)

–

–

0.88 (0.44,1.77)

0.68 (0.47,0.96)

0.85 (0.38,1.93)

2.13 (0.37,14.86)

6.63 (1.86,30.16)

1.04 (0.49,2.24)

8.10 (1.35,77.49)

ZQFTN

0.28 (0.20,0.38)

4.13 (2.27,7.71)

–

–

1.57 (0.85,2.94)

1.21 (0.94,1.54)

1.53 (0.72,3.24)

3.82 (0.68,26.04)

11.85 (3.46,52.11)

1.86 (0.94,3.72)

14.55 (2.36,140.9)

1.79 (1.31,2.44)

CM

  1. Note: Results in bold reached significant difference
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us